• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于欧洲癌症研究与治疗组织生活质量问卷的癌症治疗临床试验患者健康效用测量指标。

A patient-based utility measure of health for clinical trials of cancer therapy based on the European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire.

作者信息

Pickard A Simon, Shaw James W, Lin Hsiang-Wen, Trask Peter C, Aaronson Neil, Lee Todd A, Cella David

机构信息

Center for Pharmacoeconomic Research, College of Pharmacy, University of Illinois at Chicago, Chicago, IL 60612-7230, USA.

出版信息

Value Health. 2009 Sep;12(6):977-88. doi: 10.1111/j.1524-4733.2009.00545.x. Epub 2009 Apr 23.

DOI:10.1111/j.1524-4733.2009.00545.x
PMID:19402850
Abstract

BACKGROUND

The European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire (QLQ-C30) is a widely used quality-of-life measure in oncology. The ability to translate QLQ-C30 responses into utility scores would further expand its use in medical decision-making. The aims of this study were to: 1) map QLQ-C30 responses onto patient time trade-off utility scores; and 2) compare a multiattribute approach to a global evaluation approach to modeling utility scores.

METHODS

Two distinct approaches were applied to data from 1432 cancer patients. The multiattribute approach used psychometric analysis and expert input to select a subset of functioning and symptom scale items for modeling. The second approach focused on global health and quality-of-life items based on a conceptual model. Model selection criteria included parsimony, statistical significance and logical consistency of parameter estimates, predictive accuracy, number of states described, and scale range.

RESULTS

The optimal multiattribute model included nine variables for five items from different scales, described 144 unique states, predicted values ranging from 0.63 to 1.00, but it had poor predictive accuracy (cross-validation pseudo-R(2) = 0.056). The best-fitting global approach-based model described 24 unique states using eight indicators for two items from one scale (plus a constant) and predicted values ranging from 0.17 to 1.00 (cross-validation pseudo-R(2) = 0.127).

CONCLUSIONS

Multiattribute models produced a greater number of unique predicted values, while global models exhibited more desirable statistical properties and a wider range of values. The recommended models will enable users to predict cancer patients' utilities from existing and future QLQ-C30 data sets.

摘要

背景

欧洲癌症研究与治疗组织生活质量问卷(QLQ-C30)是肿瘤学中广泛使用的生活质量测量工具。将QLQ-C30的回答转化为效用分数的能力将进一步扩大其在医疗决策中的应用。本研究的目的是:1)将QLQ-C30的回答映射到患者时间权衡效用分数上;2)比较多属性方法和全局评估方法对效用分数进行建模。

方法

对1432名癌症患者的数据应用了两种不同的方法。多属性方法使用心理测量分析和专家意见来选择功能和症状量表项目的一个子集进行建模。第二种方法基于概念模型关注全球健康和生活质量项目。模型选择标准包括简约性、参数估计的统计显著性和逻辑一致性、预测准确性、描述的状态数量以及量表范围。

结果

最优的多属性模型包括来自不同量表的五个项目的九个变量,描述了144个独特状态,预测值范围为0.63至1.00,但预测准确性较差(交叉验证伪R(2)=0.056)。基于全局方法的最佳拟合模型使用来自一个量表的两个项目(加一个常数)的八个指标描述了24个独特状态,预测值范围为0.17至1.00(交叉验证伪R(2)=0.127)。

结论

多属性模型产生了更多数量的独特预测值,而全局模型表现出更理想的统计特性和更广泛的值范围。推荐的模型将使用户能够从现有的和未来的QLQ-C30数据集中预测癌症患者的效用。

相似文献

1
A patient-based utility measure of health for clinical trials of cancer therapy based on the European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire.基于欧洲癌症研究与治疗组织生活质量问卷的癌症治疗临床试验患者健康效用测量指标。
Value Health. 2009 Sep;12(6):977-88. doi: 10.1111/j.1524-4733.2009.00545.x. Epub 2009 Apr 23.
2
Predicting SF-6D from the European Organization for Treatment and Research of Cancer Quality of Life Questionnaire scores in patients with colorectal cancer.预测结直肠癌患者欧洲癌症研究与治疗组织生活质量问卷评分的 SF-6D 得分。
Value Health. 2013 Mar-Apr;16(2):373-84. doi: 10.1016/j.jval.2012.12.004.
3
Assessment of change of quality of life in terminally ill patients under cancer pain management using the EORTC Core Quality of Life Questionnaire (QLQ-C30) in a Korean sample.使用欧洲癌症研究与治疗组织核心生活质量问卷(QLQ-C30)对韩国样本中接受癌症疼痛管理的晚期患者的生活质量变化进行评估。
Oncology. 2008;74 Suppl 1:7-12. doi: 10.1159/000143212. Epub 2008 Aug 28.
4
Deriving a Preference-Based Measure for Myelofibrosis from the EORTC QLQ-C30 and the MF-SAF.基于欧洲癌症研究与治疗组织核心生活质量问卷(EORTC QLQ-C30)和骨髓纤维化症状评估量表(MF-SAF)得出骨髓纤维化的偏好性测量指标。
Value Health. 2015 Sep;18(6):846-55. doi: 10.1016/j.jval.2015.07.004. Epub 2015 Aug 24.
5
The European Organization for Research and Treatment of Cancer QLQ-C30: an examination into the cultural validity and reliability of the Turkish version of the EORTC QLQ-C30.欧洲癌症研究与治疗组织QLQ-C30:对欧洲癌症研究与治疗组织QLQ-C30土耳其语版本的文化效度和信度的考察。
Eur J Cancer Care (Engl). 2004 May;13(2):135-44. doi: 10.1111/j.1365-2354.2003.00435.x.
6
Summary scores captured changes in subjects' QoL as measured by the multiple scales of the EORTC QLQ-C30.总结评分捕捉到了患者生活质量的变化,这些变化是通过 EORTC QLQ-C30 的多个量表来衡量的。
J Clin Epidemiol. 2015 Aug;68(8):895-902. doi: 10.1016/j.jclinepi.2015.02.011. Epub 2015 Mar 3.
7
Quality of life of head and neck cancer patient: validation of the European organization for research and treatment of cancer QLQ-C30 and European organization for research and treatment of cancer QLQ-H&N 35 in Indian patients.头颈癌患者的生活质量:欧洲癌症研究与治疗组织QLQ-C30和欧洲癌症研究与治疗组织QLQ-H&N 35在印度患者中的验证。
Indian J Cancer. 2005 Oct-Dec;42(4):178-84.
8
Validity and reliability of the Swedish version of the Memorial Symptom Assessment Scale (MSAS): an instrument for the evaluation of symptom prevalence, characteristics, and distress.《纪念症状评估量表(MSAS)瑞典语版的有效性和可靠性:用于评估症状发生率、特征和痛苦的工具》。
J Pain Symptom Manage. 2013 Jul;46(1):131-41. doi: 10.1016/j.jpainsymman.2012.07.023. Epub 2012 Nov 27.
9
Health-related quality of life in early breast cancer.早期乳腺癌患者的健康相关生活质量
Dan Med Bull. 2010 Sep;57(9):B4184.
10
Symptoms and quality of life in chronic pancreatitis assessed by structured interview and the EORTC QLQ-C30 and QLQ-PAN26.通过结构化访谈以及欧洲癌症研究与治疗组织核心问卷(QLQ-C30)和慢性胰腺炎问卷(QLQ-PAN26)评估慢性胰腺炎的症状和生活质量。
Am J Gastroenterol. 2005 Apr;100(4):918-26. doi: 10.1111/j.1572-0241.2005.40859.x.

引用本文的文献

1
Quality of Life After Curative Resection for Gastric Cancer: Survey Metrics and Implications of Surgical Technique.胃癌根治性切除术后的生活质量:调查指标及手术技术的影响
J Surg Res. 2020 Jul;251:168-179. doi: 10.1016/j.jss.2020.02.005. Epub 2020 Mar 7.
2
QLU-C10D: a health state classification system for a multi-attribute utility measure based on the EORTC QLQ-C30.QLU-C10D:一种基于欧洲癌症研究与治疗组织核心生活质量问卷(EORTC QLQ-C30)的多属性效用测量健康状态分类系统。
Qual Life Res. 2016 Mar;25(3):625-36. doi: 10.1007/s11136-015-1217-y. Epub 2016 Jan 20.
3
Mapping Functions in Health-Related Quality of Life: Mapping from Two Cancer-Specific Health-Related Quality-of-Life Instruments to EQ-5D-3L.
健康相关生活质量中的映射函数:从两种癌症特异性健康相关生活质量工具映射到EQ-5D-3L
Med Decis Making. 2015 Oct;35(7):912-26. doi: 10.1177/0272989X15587497. Epub 2015 May 21.
4
Using existing data to identify candidate items for a health state classification system in multiple sclerosis.利用现有数据确定用于多发性硬化症健康状态分类系统的候选条目。
Qual Life Res. 2014 Jun;23(5):1445-57. doi: 10.1007/s11136-013-0604-5. Epub 2013 Dec 15.
5
Evaluation of content on EQ-5D as compared to disease-specific utility measures.评估 EQ-5D 与疾病特异性效用测量的内容。
Qual Life Res. 2013 May;22(4):853-74. doi: 10.1007/s11136-012-0207-6. Epub 2012 Jun 23.
6
Mapping the QLQ-C30 quality of life cancer questionnaire to EQ-5D patient preferences.将 QLQ-C30 癌症生活质量问卷映射到 EQ-5D 患者偏好上。
Eur J Health Econ. 2010 Aug;11(4):427-34. doi: 10.1007/s10198-010-0233-7. Epub 2010 May 16.